Page last updated: 2024-11-07

idoxuridine and Multiple Myeloma

idoxuridine has been researched along with Multiple Myeloma in 2 studies

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Busk, CM1
Earl, HM1
Wrigley, PF1
Lister, TA1
Haraldsdóttir, V1
Haanen, C1
Kalsbeek-Batenburg, E1
Olthuis, F1

Other Studies

2 other studies available for idoxuridine and Multiple Myeloma

ArticleYear
Triple drug therapy of Herpes zoster infection occurring in patients with reticulo-endothelial neoplasia--a preliminary study.
    The Journal of antimicrobial chemotherapy, 1980, Volume: 6, Issue:6

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Herpes Zoster; Hodgkin Disease; Humans; Idoxuridine;

1980
S-phase cells of the lymphoplasmocytic compartment in hyperdiploid multiple myeloma are diploid cells.
    Cytometry, 1995, Oct-01, Volume: 21, Issue:2

    Topics: Aged; Bone Marrow; Cell Cycle; Diploidy; DNA, Neoplasm; Female; Flow Cytometry; G1 Phase; Hematopoie

1995